3-(4-(4-Ethoxyphenyl)-5-((2-methylbenzyl)thio)-4H-1,2,4-triazol-3-yl)pyridine

Catalog No. :
ACCHJO101
CAS No. :
477330-16-8
Molecular Formula :
C23H22N4OS
Molecular Weight :
402.52

IUPAC Name:3-(4-(4-ethoxyphenyl)-5-((2-methylbenzyl)thio)-4H-1,2,4-triazol-3-yl)pyridine

3-(4-(4-Ethoxyphenyl)-5-((2-methylbenzyl)thio)-4H-1,2,4-triazol-3-yl)pyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-(4-(4-Ethoxyphenyl)-5-((2-methylbenzyl)thio)-4H-1,2,4-triazol-3-yl)pyridine
IUPAC Name3-(4-(4-ethoxyphenyl)-5-((2-methylbenzyl)thio)-4H-1,2,4-triazol-3-yl)pyridine
MDL No.MFCD03225095
Molecular FormulaC23H22N4OS
Molecular Weight402.52
SMILESCC1=CC=CC=C1CSC2=NN=C(C3=CC=CN=C3)N2C4=CC=C(OCC)C=C4
InChI KeyDMMGAUKSJIZDJX-UHFFFAOYSA-N
SynonymSALOR-INT L243698-1EA;3-(4-(4-ETHOXYPHENYL)-5-((2-METHYLBENZYL)THIO)-4H-1,2,4-TRIAZOL-3-YL)PYRIDINE;Pyridine, 3-[4-(4-ethoxyphenyl)-5-[[(2-methylphenyl)methyl]thio]-4H-1,2,4-triazol-3-yl]-
CAS No.477330-16-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACCHJO101 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCHJO101 route product structure diagram
    ACCHJO101477330-16-8
Inquiry

2. ACCHJO101 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCHJO101 route product structure diagram
    ACCHJO101477330-16-8
Inquiry

Comments (0)